医療機器検査の世界市場2022-2028:産業動向、シェア、規模、成長、機会・予測

◆英語タイトル:Medical Device Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書(IMARC23FE0064)◆商品コード:IMARC23FE0064
◆発行会社(リサーチ会社):IMARC
◆発行日:2023年2月1日
◆ページ数:147
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社発行の当調査資料によると、2022年118億ドルであった世界の医療機器検査市場規模が2028年には175億ドルに達し、予測期間中、年平均6.6%成長すると予測されています。当書は、医療機器検査の世界市場について総合的に調査・分析されたレポートです。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、サービス別(試験サービス、検査サービス、その他)分析、種類別(社内、外部委託)分析、検査別(生体適合性検査、化学的検査、バイオバーデン測定、抗菌性&無菌性検査、その他)分析、デバイスクラス別(クラスI、クラスII、クラスIII)分析、地域別(北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ)分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目がまとめられています。なお、当書に掲載されている企業情報には、American Preclinical Services LLC、Charles River Laboratories International Inc.、Element Materials Technology、Eurofins Scientific LLC、Intertek Group Plc、North American Science Associates Inc.、Pace Analytical Services LLC (LAB Holdings Inc.)、SGS SA、Sterigenics U.S. LLC (Sotera Health LLC)、Toxikon Corporation、TÜV Rheinland Aktiengesellschaft、TÜV SÜD Aktiengesellschaft、WuXi AppTecなどが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション

・世界の医療機器検査市場規模:サービス別
- 試験サービスの市場規模
- 検査サービスの市場規模
- その他サービスの市場規模

・世界の医療機器検査市場規模:種類別
- 社内検査の市場規模
- 外部委託検査の市場規模

・世界の医療機器検査市場規模:検査別
- 生体適合性検査の市場規模
- 化学的検査の市場規模
- バイオバーデン測定の市場規模
- 抗菌性&無菌性検査の市場規模
- その他検査の市場規模

・世界の医療機器検査市場規模: デバイスクラス別
- クラスIの市場規模
- クラスIIの市場規模
- クラスIIIの市場規模

・世界の医療機器検査市場規模:地域別
- 北米の医療機器検査市場規模
- アジア太平洋の医療機器検査市場規模
- ヨーロッパの医療機器検査市場規模
- 中南米の医療機器検査市場規模
- 中東/アフリカの医療機器検査市場規模

・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況
・主要企業情報

The global medical device testing market size reached US$ 11.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 17.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.

Medical device testing refers to the process of inspecting the design and production efficiency of various active and non-active medical equipment. It involves prototype, biocompatibility, chemistry, microbiology and sterility testing, package validation, electrical, mechanical and functional safety assessments and software testing. These tests are conducted for cardiovascular, neuro and orthopedic devices, dental implants and material components. The service providers also offer in-house or outsourced testing, inspection and certification services to the consumers. These services ensure that the device is reliable and safe to use in clinical or emergency settings. As a result, medical device testing finds extensive applications across hospitals, clinics and other healthcare and diagnostic centers.

Significant growth in the medical industry, along with the increasing requirement of validation and verification of medical devices, represents one of the key factors creating a positive outlook for the market. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for efficient testing systems to develop low-cost medical devices which is further augmenting the market growth. Additionally, various technological advancements, such as the utilization of artificial intelligence (AI), robotics and automation in the testing processes, are acting as other major growth-inducing factors. Device manufacturers use automated quality assurance tools to increase the accuracy of clinical equipment and wearable medical devices with minimal human intervention in the testing processes. Other factors, such as increasing complexities in product design, along with the widespread adoption of outsourced testing services, are anticipated to drive the market further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical device testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, type, testing type, device class and device type.

Breakup by Service:

Testing Services
Inspection Services
Others

Breakup by Type:

In-House
Outsourced

Breakup by Testing Type:

Biocompatibility Testing
Chemistry Testing
Bio-Burden Determination
Anti-Microbial Activity and Sterility Testing
Others

Breakup by Device Class:

Class I
Class II
Class III

Breakup by Device Type:

Implantable Medical Devices
Non-Active Medical Devices
In-Vitro Diagnostic Medical Devices
Ophthalmic Medical Devices
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being American Preclinical Services LLC, Charles River Laboratories International Inc., Element Materials Technology, Eurofins Scientific LLC, Intertek Group Plc, North American Science Associates Inc., Pace Analytical Services LLC (LAB Holdings Inc.), SGS SA, Sterigenics U.S. LLC (Sotera Health LLC), Toxikon Corporation, TÜV Rheinland Aktiengesellschaft, TÜV SÜD Aktiengesellschaft and WuXi AppTec.

Key Questions Answered in This Report:
How has the global medical device testing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global medical device testing market?
What are the key regional markets?
What is the breakup of the market based on the service?
What is the breakup of the market based on the type?
What is the breakup of the market based on the testing type?
What is the breakup of the market based on the device class?
What is the breakup of the market based on the device type?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global medical device testing market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Medical Device Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Service
6.1 Testing Services
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inspection Services
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 In-House
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Outsourced
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Testing Type
8.1 Biocompatibility Testing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Chemistry Testing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Bio-Burden Determination
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Anti-Microbial Activity and Sterility Testing
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Device Class
9.1 Class I
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Class II
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Class III
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Device Type
10.1 Implantable Medical Devices
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Non-Active Medical Devices
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 In-Vitro Diagnostic Medical Devices
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Ophthalmic Medical Devices
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 American Preclinical Services LLC
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Charles River Laboratories International Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Element Materials Technology
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Eurofins Scientific LLC
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Intertek Group Plc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 North American Science Associates Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Pace Analytical Services LLC (LAB Holdings Inc.)
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 SGS SA
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Sterigenics U.S. LLC (Sotera Health LLC)
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Toxikon Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 TÜV Rheinland Aktiengesellschaft
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 TÜV SÜD Aktiengesellschaft
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.13 WuXi AppTec
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療機器検査の世界市場2022-2028:産業動向、シェア、規模、成長、機会・予測(Medical Device Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆